Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ 0
Profit
Healthy€ 93.9 million
▼ 75% vs 2024
Debts
Low€ 125.3 million
▲ 5% vs 2024
STERIGENICS from Leuven, company number BE0427835425, closed financial year 2025 with a result of € 93.9 million after tax. For that financial year STERIGENICS recorded a gross margin of € 0 and equity of € 469.5 million. Compared with financial year 2024, the result moved from € 375.8 million to € 93.9 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
What happened at STERIGENICS?
What happened at STERIGENICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Ronald Asselberghs stepped down as director. NBB
- Robin Van Den Bergh stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 93.9 million (▼ 75% vs 2024). Source: NBB ↗
- Ronald Asselberghs became a director. NBB
- Pontus Rundstrom Lars stepped down as director. NBB
- Pontus Rundstrom Lars became a director. NBB
- Robin Van Den Bergh became a director. NBB
- New establishment in Leuven. KBO
In short
From € 1.7 million loss in 2022 to € 93.9 million profit in 2025.
Paid € 90,945 in corporate taxes since 2022.
Best year ever: 2024, with € 375.8 million profit.
Paid out € 97.6 million in dividends to the owners in total.
A new publication or filing at STERIGENICS? We notify you, reason included.
Follow STERIGENICSNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Sotera Health Holdings LLC (100%). It owns 100% of STERIGENICS SHANGHAI ETO Ltd. and 99% of Nelson Labs itself.
Directors
According to the 2025 annual accounts
Ronald Asselberghs
Director
since 2025 · until 2031
Pontus Rundstrom Lars
Director
since 2025 · until 2025
since 2025 · until 2031
Shareholders
Sotera Health Holdings LLC
100%
Participations
STERIGENICS SHANGHAI ETO Ltd.
100%
99%
Establishments
Establishment units
Physical locations of this company
Vaartdijk 3 box 302
3018 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 30 companies are registered at this address.
DIMA
€ 43,574 gross margin · 2025
REMY COMMUNICATION
€ 563,687 gross margin · 2025
REGIONALE OMROEP BRABANT
€ 669,322 gross margin · 2025
ELSYCA
€ 3.5 million gross margin · 2025
HOMO SAPIENS SAPIENS
€ 454,215 gross margin · 2025
+25 more
Details
- Company number
- 0427.835.425
- VAT number
- BE 0427.835.425
- Registered office
- Vaartdijk 3 bus 302, 3018 Leuven
- Names & denominations
- STERIGENICS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 September 1985
- Peppol
- Active · Active since 2 Jan 2026
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Technische studiën en ingenieursactiviteiten
Andere reinigingsactiviteiten
Industriële reiniging
Groothandel in farmaceutische producten